FDA panel recommends mRNA flu vaccine for older adults
Summary
An FDA advisory panel has recommended approving Moderna’s new flu vaccine made with mRNA technology. The panel voted 9-0 that the vaccine is safe and effective for people aged 50 and older.Key Facts
- The vaccine is based on mRNA technology, a first for flu shots.
- The FDA panel reviewed Moderna’s mFlusiva vaccine.
- The recommendation was unanimous with a 9-0 vote.
- The vaccine is aimed at people 50 to 64 years old and those 65 and older.
- Moderna is currently seeking official FDA approval for the vaccine.
- mRNA technology has been used before in COVID-19 vaccines.
- This new flu vaccine could offer better protection for older adults.
- The FDA panel acts as an independent group advising the agency on vaccine safety and effectiveness.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.